Replies to post #187466 on Biotech Values

[DewDiligence]

The term gross to net* does not incorporate lower revenue attributable to a shorter duration of treatment. Very lame attempt by the Wells Fargo analyst.

*Actually a misnomer insofar as it measures net to gross, not the other way around.